SA
BSX icon

SpiderRock Advisors’s Boston Scientific BSX Stock Holding History

SpiderRock Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$746K Sell
8,906
-1,398
-14% -$110K 0.01% 528
2024
Q2 		$794K Buy
+10,304
New +$754K 0.02% 455

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SpiderRock Advisors's BSX Position: Q3 2024 in Review

SpiderRock Advisors reduced its Boston Scientific (BSX) stake by 14% in Q3 2024, selling an estimated $110K and leaving 8,906 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #528.

SpiderRock Advisors first reported a position in BSX in Q2 2024 and has held it in 2 quarters since. The position peaked at $794K in Q2 2024. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • SpiderRock Advisors held 8,906 shares of Boston Scientific worth $746K as of Q3 2024.
  • SpiderRock Advisors sold 1,398 Boston Scientific shares in Q3 2024, an estimated $110K.
  • Boston Scientific made up 0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #528 holding.
  • SpiderRock Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 2 quarters since.
  • SpiderRock Advisors's Boston Scientific position peaked at $794K in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.